OTC · CIMVF
Pideka Group Inc.
$0.01$0.00 (0.0%)
Pideka Group Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
Loading market information…
OTC · CANB · USD
Stock price, earnings
Quote as of Jan 15, 2026, 02:30 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Can B Corp.’s quoted price sits in the lower half of its reported 52-week range, 89.55% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Can B Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Can B Corp. operates within the United States, specializing in the development, manufacturing, and sale of products derived from cannabidiol (CBD). Its extensive range of hemp-based CBD offerings includes oils, topical creams, moisturizers, isolates, gel capsules, spa items, concentrates, and various lifestyle products. Customers can purchase these goods through the company's official website, automated vending machines, and via partnerships with medical professionals. The firm markets its products under distinct brand names such as Canbiola, Nu Wellness, Seven Chakras, and Pure Leaf Oil. The company, which changed its name from Canbiola Inc. to Can B Corp. in February 2020, was founded in 2005 and is headquartered in Hicksville, New York.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:19 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q1 2023 | May 22, 2023 | -$0.36-700.0% vs estimate | $939.31K-88.27% vs estimate |
|---|
| Q1 2023 | Apr 19, 2023 | -$0.62-1,140.0% vs estimate | $666.07K-89.73% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.01$0.00 (0.0%)
Pideka Group Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.04-$0.00 (-2.67%)
CBD Global Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 65.37% below the high.
$0.00-$0.00 (-85.71%)
RCMW Group, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Kallo Inc.: Healthcare · Medical - Healthcare Information Services.
$0.01+$0.01 (+166.67%)
Silo Wellness Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.50+$0.17 (+51.52%)
Irwin Naturals Inc.’s quoted price sits in the lower half of its reported 52-week range, 53.27% below the high.
$0.08-$0.09 (-51.52%)
Parnell Pharmaceuticals Holdings Ltd’s quoted price sits in the lower half of its reported 52-week range, 77.14% below the high.
$0.00-$0.00 (-15.56%)
AusCann Group Holdings Ltd: Healthcare · Drug Manufacturers - Specialty & Generic.
